Skip to main content

Table 2 Type of CMV testing and timing of CMV testing among pregnant women a and among pregnant women a with a diagnostic code for CMV, MarketScan 2009

From: Laboratory testing for cytomegalovirus among pregnant women in the United States: a retrospective study using administrative claims data

 

Pregnant womenawith CMV-specific testingb

Pregnant womenawith an ICD-9-CM diagnostic code for CMV disease and CMV-specific testingb

 

N, 1,668

N, 10

 

#

%

#

%

Type of CMV-specific Test b

CMV PCR ONLY

17

1%

1

10%

CMV DFA ONLY

1

0%

0

0%

CMV Serology ONLY (CMV IgG, IgM, and EIA)

741

44%

5

50%

CMV PCR AND CMV Serology

8

0%

0

0%

CMV PCR AND Non-Specific Culture or PCR

24

1%

2

20%

CMV PCR, CMV Serology, AND Non-specific Culture or PCR

13

1%

0

0%

CMV DFA, CMV Serology, AND Non-Specific Culture or PCR

1

0%

0

0%

CMV Serology AND Non-specific Culture or PCR

863

52%

2

20%

Gestational Age when CMV-Specific Testing Conducted c

1st Trimester

863

52%

5

50%

2nd Trimester

395

24%

4

40%

3rd Trimester

410

24%

1

10%

  1. Note: CMV, cytomegalovirus; ICD-9-CM, International Classification of Diseases-9th revision, Clinical Modification; PCR, polymerase chain reaction; IgG, Immunoglobulin G; IgM, Immunoglobulin M; DFA, direct fluorescent testing; EIA, enzyme immunoassay.
  2. aPregnant women defined as female enrollees who were 1) aged 15–44 years, 2) enrolled for the entire year in 2009, and 3) had a delivery code (defined in Appendix) between October-December 2009.
  3. bCMV-specific testing includes CMV IgG, CMV IgM, CMV DFA, CMV EIA, and CMV PCR testing.
  4. cDate of first claim with a delivery code (defined in Appendix) was used to approximate delivery date in order to calculate the approximate age when the first CMV-specific testing was done. We assumed that CMV-specific testing which occurred 0–13 weeks was within the 1st trimester, testing within weeks 14–26 to be in the 2nd trimester, and testing within weeks 27–42 to be in the 3rd trimester. Pregnant women with testing that occurred before (<0 weeks) or after (≥43 weeks) pregnancy were excluded.